The use of HIV-1 integrase inhibitors in antiretroviral naive patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Virology,Infectious Diseases,Oncology (nursing),Oncology,Hematology,Immunology
Reference23 articles.
1. Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
2. Metabolic and Cardiovascular Complications in HIV-Infected Patients: New Challenges for a New Age
3. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
4. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
5. Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. HIV and Dyslipidemia;Contemporary Cardiology;2020-12-16
2. Atrial fibrillation and human immunodeficiency virus type‐1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy;British Journal of Clinical Pharmacology;2019-01-11
3. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens;HIV Medicine;2017-10-06
4. Single- and Multiple-Dose Pharmacokinetics of Once-Daily Formulations of Raltegravir;Clinical Pharmacology in Drug Development;2017-04-17
5. Analyse des motivations du choix des antirétroviraux (ARV) prescrits chez des patients infectés par le VIH (PVVIH) naïfs;La Revue de Médecine Interne;2016-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3